Publications

A protocol for a living mapping review of global research funding for infectious diseases with a pandemic potential – PANDEMIC PACT

Seminog O. et al, (2024), Wellcome Open Research, 9, 156 - 156

Improving coherence of global research funding: Pandemic PACT

Norton A. et al, (2024), The Lancet, 403, 1233 - 1233

Funding and COVID-19 research in Africa: two years on, are the research needs of Africa being met?

Antonio E. et al, (2023), Open Research Africa, 6, 16 - 16

A review of new challenges and solutions to the timely and effective implementation of clinical research responses to high priority diseases of epidemic and pandemic potential: A scoping review protocol

Kadri-Alabi Z. et al, (2023), Open Research Europe, 3, 139 - 139

A living mapping review for COVID-19 funded research projects: final (27 month) update

Bucher A. et al, (2023), Wellcome Open Research, 5, 209 - 209

How funders can support improved clinical trial practice for outbreaks.

Foster I. et al, (2023), Lancet (London, England), 402

A living mapping review for COVID-19 funded research projects: two year update

Bucher A. et al, (2023), Wellcome Open Research, 5, 209 - 209

Scoping review protocol on research prioritisation for preparedness and response to outbreaks of high consequence pathogens

Antonio E. et al, (2023), Open Research Europe, 3, 16 - 16

Scoping review protocol on research prioritisation for preparedness and response to outbreaks of high consequence pathogens.

Antonio E. et al, (2023), Open research Europe, 3

Severe acute hepatitis of unknown aetiology in children—what is known?

Khader S. et al, (2022), BMC Medicine, 20

Sudan virus disease outbreak in Uganda: urgent research gaps

Ibrahim SK. et al, (2022), BMJ Global Health, 7, e010982 - e010982

A living mapping review for COVID-19 funded research projects: 21 month update

Bucher A. et al, (2022), Wellcome Open Research, 5, 209 - 209

A living mapping review for COVID-19 funded research projects: 18 month update

Bucher A. et al, (2022), Wellcome Open Research, 5, 209 - 209

Availability, scope and quality of monkeypox clinical management guidelines globally: a systematic review

Webb E. et al, (2022), BMJ Global Health, 7, e009838 - e009838

A living mapping review for COVID-19 funded research projects: one year update

Norton A. et al, (2022)

Availability, scope, and quality of monkeypox clinical management guidelines globally: a systematic review

Webb E. et al, (2022)

A living mapping review for COVID-19 funded research projects: nine-month update

Norton A. et al, (2021), Wellcome Open Research, 5, 209 - 209

Long COVID: tackling a multifaceted condition requires a multidisciplinary approach

Norton A. et al, (2021), The Lancet Infectious Diseases, 21, 601 - 602

Priorities for COVID-19 research response and preparedness in low-resource settings

Norton AJ. et al, (2021), The Lancet, 397, 1866 - 1868

A living mapping review for COVID-19 funded research projects: six-month update

Norton A. et al, (2021), Wellcome Open Research, 5, 209 - 209

Correction to Lancet Infect Dis 2021; online Feb 3. https://doi.org/10.1016/S1473-3099(21)00043-8.

(2021), The Lancet. Infectious diseases, 21

A living mapping review for COVID-19 funded research projects: three-month update

Norton A. et al, (2020), Wellcome Open Research, 5, 209 - 209

Preparing for a pandemic: highlighting themes for research funding and practice—perspectives from the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)

Norton A. et al, (2020), BMC Medicine, 18

Baseline results of a living systematic review for COVID-19 funded research projects

Norton A. et al, (2020), Wellcome Open Research, 5, 209 - 209

Strengthening the global effort on COVID-19 research

Norton A. et al, (2020), The Lancet, 396, 375 - 375

The remaining unknowns: a mixed methods study of the current and global health research priorities for COVID-19.

Norton A. et al, (2020), BMJ global health, 5

The remaining unknowns: A mixed methods study of the current and global health research priorities for COVID-19

Norton A. et al, (2020)

A living mapping review for COVID-19 funded research projects: 18 month update.

Bucher A. et al, (2020), Wellcome open research, 5

Funding and COVID-19 research priorities - are the research needs for Africa being met?

Antonio E. et al, (2020), AAS open research, 3

Two-year longitudinal survey reveals high genetic diversity of Schistosoma mansoni with adult worms surviving praziquantel treatment at the start of mass drug administration in Uganda.

Faust CL. et al, (2019), Parasites & vectors, 12

POPULATION GENETICS OF SCHISTOSOME PARASITES IN SCHOOL AGED CHILDREN BEFORE AND AFTER PRAZIQUANTEL TREATMENT

Faust C. et al, (2018), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 99, 19 - 19

Population genetic structure of Schistosoma mansoni and Schistosoma haematobium from across six sub-Saharan African countries: implications for epidemiology, evolution and control.

Gower CM. et al, (2013), Acta tropica, 128, 261 - 274

Reductions in genetic diversity of Schistosoma mansoni populations under chemotherapeutic pressure: the effect of sampling approach and parasite population definition.

French MD. et al, (2013), Acta tropica, 128, 196 - 205

The impact of single versus mixed Schistosoma haematobium and S. mansoni infections on morbidity profiles amongst school-children in Taveta, Kenya.

Gouvras AN. et al, (2013), Acta tropica, 128, 309 - 317

Genetic consequences of mass human chemotherapy for Schistosoma mansoni: population structure pre- and post-praziquantel treatment in Tanzania.

Norton AJ. et al, (2010), The American journal of tropical medicine and hygiene, 83, 951 - 957

Simultaneous infection of Schistosoma mansoni and S. rodhaini in Biomphalaria glabrata: impact on chronobiology and cercarial behaviour.

Norton A. et al, (2008), Parasites & vectors, 1

IMPLICATIONS OF THE EFFECT OF SCHISTOSOMA MANSONI AND SCHISTOSOMA HAEMATOBIUM CO-INFECTIONS ON HUMAN MORBIDITY INDICATORS

Gouvras AN. et al, (2008), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 79, 90 - 90

THE EFFECT OF PRAZIQUANTEL TREATMENT ON THE GENETIC DIVERSITY OF SCHISTOSOMA MANSONI INFECTIONS IN PRIMARY SCHOOL CHILDREN WITHIN MAYUGE DISTRICT, UGANDA

Lamberton PH. et al, (2008), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 79, 222 - 222

Inter-specific parasite competition: mixed infections of Schistosoma mansoni and S. rodhaini in the definitive host.

Norton AJ. et al, (2008), Parasitology, 135, 473 - 484

Evolutionary concepts in predicting and evaluating the impact of mass chemotherapy schistosomiasis control programmes on parasites and their hosts.

Webster JP. et al, (2008), Evolutionary applications, 1, 66 - 83

Cookies on this website

Publications